Page 1771 - Saunders Comprehensive Review For NCLEX-RN
P. 1771

7. Uncontrolled hypertension
                                             8. Recent, prolonged cardiopulmonary resuscitation
                                             9. Known allergy to the product or its preservatives
                                C. Side and adverse effects
                                             1. Bleeding
                                             2. Dysrhythmias
                                             3. Allergic reactions
                                D. Interventions
                                             1. Determine aPTT, PT, fibrinogen level, hematocrit, and
                                                platelet count.
                                             2. Monitor vital signs.
                                             3. Assess pulses.
                                             4. Monitor for bleeding and check all excretions for
                                                occult blood.

                                                      5. Monitor for neurological changes such as

                                                slurred speech, lethargy, confusion, and hemiparesis.
                                             6. Monitor for hypotension and tachycardia.
                                             7. Avoid injections and venipunctures if possible.
                                             8. Apply direct pressure over a puncture site for 20 to 30
                                                minutes.
                                             9. Handle the client gently and as little as possible when
                                                moving.
                                           10. Instruct the client to use an electric razor for shaving
                                                and to brush teeth gently.

                                                    11. Withhold the medication if bleeding develops,

                                                and notify the primary health care provider (PHCP).

                                                    12. Antidote: Aminocaproic acid is the antidote.





                                                       Bleeding is the primary concern for a client taking an

                                                anticoagulant, thrombolytic, or antiplatelet medication.
                    III. Antiplatelet Medications (Box 53-4)
                                A. Description
                                             1. Antiplatelet medications inhibit the aggregation of
                                                platelets in the clotting process, thereby prolonging
                                                the bleeding time.
                                             2. Antiplatelet medications may be used with
                                                anticoagulants.
                                             3. Used in the prophylaxis of long-term complications
                                                following myocardial infarction, coronary
                                                revascularization, stents, and stroke.
                                             4. These medications are contraindicated in those with
                                                bleeding disorders and known sensitivity.




                                                         1771
   1766   1767   1768   1769   1770   1771   1772   1773   1774   1775   1776